E-labelling in the EU: will devices sector follow the IVDs?
This article was originally published in Clinica
Executive Summary
The first draft of a European IVD e-labelling guidance document should be ready for presentation to the next European Commission Medical Devices Experts Group in July. That is the hope of the European Diagnostics Manufacturers Association (EDMA) which has been working on a guidance document, along with the French, Irish and UK competent authorities.
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.